Patents by Inventor Johan Selmer

Johan Selmer has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF DERMATOLOGICAL CONDITIONS
    Publication number: 20230414699
    Abstract: Provided is a pharmaceutical composition which comprises a nucleophilic compound capable of inhibiting carbamylation, for use in the treatment of a condition involving cutaneous or connective tissue damage. A method for treating a condition involving cutaneous or connective tissue damage in a patient, is also provided, said method comprising administering a said pharmaceutical composition to said patient.
    Type: Application
    Filed: October 8, 2021
    Publication date: December 28, 2023
    Applicant: MC2 Therapeutics Ltd
    Inventors: Torkil Menne, Johan Selmer, Jesper Lange, Jon Bondebjerg, Michelle Georgiou
  • FORMULATION FOR USE IN THE TREATMENT OF UREMIC PRURITUS
    Publication number: 20210000796
    Abstract: There is provided a topical formulation comprising a nucleophile, such as amino acids and most polypetides and/or a derivative thereof, for use in the treatment or prevention of itchy dry skin caused by urea, such as in uremic pruritus, of a subject. The amino acid may be histidine and the derivative may be a histidine degradation product, a peptide of histidine, a peptide of histidine and one or more additional amino acids, and a pharmaceutically-acceptable salt of histidine.
    Type: Application
    Filed: September 18, 2020
    Publication date: January 7, 2021
    Applicant: DRUG DELIVERY SOLUTIONS APS
    Inventors: Torkil MENNE, Johan SELMER, Jesper LANGE, Michelle GEORGIOU, Derek WHEELER, David EVANS
  • Formulation for use in the treatment of uremic pruritus
    Patent number: 10806721
    Abstract: There is provided a topical formulation comprising a nucleophile, such as amino acids and most polypeptides and/or a derivative thereof, for use in the treatment or prevention of itchy dry skin caused by urea, such as in uremic pruritus, of a subject. The amino acid may be histidine and the derivative may be a histidine degradation product, a peptide of histidine, a peptide of histidine and one or more additional amino acids, and a pharmaceutically-acceptable salt of histidine.
    Type: Grant
    Filed: June 16, 2017
    Date of Patent: October 20, 2020
    Assignee: DRUG DELIVERY SOLUTIONS APS
    Inventors: Torkil Menne, Johan Selmer, Jesper Lange, Michelle Georgiou, Derek Wheeler, David Evans
  • FORMULATION FOR USE IN THE TREATMENT OF UREMIC PRURITUS
    Publication number: 20190321336
    Abstract: There is provided a topical formulation comprising a nucleophile, such as amino acids and most polypeptides and/or a derivative thereof, for use in the treatment or prevention of itchy dry skin caused by urea, such as in uremic pruritus, of a subject. The amino acid may be histidine and the derivative may be a histidine degradation product, a peptide of histidine, a peptide of histidine and one or more additional amino acids, and a pharmaceutically-acceptable salt of histidine.
    Type: Application
    Filed: June 16, 2017
    Publication date: October 24, 2019
    Inventors: Torkil MENNE, Johan SELMER, Jesper LANGE, Michelle GEORGIOU, Derek WHEELER, David EVANS
  • A Method for Topically Treating Actinic Keratosis on the Trunk (except chest) and Extremities with Ingenol 3-(3,5-diethylisoxazole-4-carboxylate)
    Publication number: 20170258769
    Abstract: The invention relates to the treatment of actinic keratosis on the trunk (except chest) and extremities with ingenol 3-(3,5-diethylisoxazole-4-carboxylate).
    Type: Application
    Filed: November 27, 2015
    Publication date: September 14, 2017
    Inventors: Casper Clemmensen, Johan Selmer, Kim Mark Knudsen
  • Method for Topically Treating Actinic Keratosis on the Full Face or 250 cm2 on the Chest with Ingenol 3-(3,5-diethylisoxazole-4-carboxylate)
    Publication number: 20170258770
    Abstract: The invention relates to the treatment of actinic keratosis on the full face or 250 cm2 on the chest with ingenol 3-(3,5-diethylisoxazole-4-carboxylate).
    Type: Application
    Filed: November 27, 2015
    Publication date: September 14, 2017
    Inventors: Casper Clemmensen, Johan Selmer, Kim Mark Knudsen
  • A Method for Topically Treating Actinic Keratosis on the Scalp with Ingenol 3-(3,5-diethylisoxazole-4-carboxylate)
    Publication number: 20170258756
    Abstract: The invention relates to the treatment of actinic keratosis on the scalp with ingenol 3-(3,5-diethylisoxazole-4-carboxylate).
    Type: Application
    Filed: November 27, 2015
    Publication date: September 14, 2017
    Inventors: Casper Clemmensen, Johan Selmer, Kim Mark Knudsen
  • Method for topically treating actinic keratosis on the trunk (except chest) or extremities with ingenol 3-(3,5-diethylisoxazole-4-carboxylate)
    Patent number: 9713608
    Abstract: The invention relates to the treatment of actinic keratosis on the trunk (except chest) or Extremities with ingenol 3-(3,5-diethylisoxazole-4-carboxylate).
    Type: Grant
    Filed: October 27, 2014
    Date of Patent: July 25, 2017
    Assignee: LEO Laboratories Limited
    Inventors: Johan Selmer, Kim Mark Knudsen
  • Method for Topically Treating Actinic Keratosis on the Trunk (except chest) or Extremities with Ingenol 3-(3,5-diethylisoxazole-4-carboxylate)
    Publication number: 20160089362
    Abstract: The invention relates to the treatment of actinic keratosis on the trunk (except chest) or Extremities with ingenol 3-(3,5-diethylisoxazole-4-carboxylate).
    Type: Application
    Filed: May 5, 2015
    Publication date: March 31, 2016
    Inventors: Johan Selmer, Kim Mark Knudsen
  • Method for Topically Treating Actinic Keratosis on the Trunk (except chest) Or Extremities with ingenol 3-(3,5-diethylisoxazole-4-carboxylate)
    Publication number: 20150258071
    Abstract: The invention relates to the treatment of actinic keratosis on the trunk (except chest) or Extremities with ingenol 3-(3,5-diethylisoxazole-4-carboxylate).
    Type: Application
    Filed: October 27, 2014
    Publication date: September 17, 2015
    Inventors: Johan Selmer, Kim Mark Knudsen
  • METHOD OF TREATING ACTINIC KERATOSIS ON THE FULL BALDING SCALP WITH INGENOL 3-(3,5-DIETHYLISOXAZOLE-4-CARBOXYLATE)
    Publication number: 20150119433
    Abstract: The invention relates to the topical treatment of actinic keratosis on the full balding scalp with ingenol 3-(3,5-diethylisoxazole-4-carboxylate).
    Type: Application
    Filed: October 27, 2014
    Publication date: April 30, 2015
    Inventors: Johan Selmer, Kim Mark Knudsen
  • Method for Topically Treating Actinic Keratosis with ingenol 3-(3,5-diethylisoxazole-4-carboxylate)
    Publication number: 20150119434
    Abstract: The invention relates to the topical treatment of actinic keratosis with ingenol 3-(3,5-diethylisoxazole-4-carboxylate).
    Type: Application
    Filed: October 27, 2014
    Publication date: April 30, 2015
    Inventors: Johan Selmer, Kim Mark Knudsen
  • GLP-1 AGONIST AND CARDIOVASCULAR COMPLICATIONS
    Publication number: 20140206615
    Abstract: Methods and uses for the treatment and prevention of cardiac and cardiovascular diseases comprising administration of a GLP-1 agonist.
    Type: Application
    Filed: March 28, 2014
    Publication date: July 24, 2014
    Applicant: NOVO NORDISK A/S
    Inventors: Liselotte Bjerre Knudsen, Bidda Charlotte Rolin, Richard David Carr, Johan Selmer, Jens Larsen, Bodil Elbrond, Lars Bo Nielsen, Christina Christoffersen
  • GLP-1 Agonist and Cardiovascular Complications
    Publication number: 20130338071
    Abstract: Methods and uses for the treatment and prevention of cardiac and cardiovascular diseases comprising administration of a GLP-1 agonist.
    Type: Application
    Filed: August 26, 2013
    Publication date: December 19, 2013
    Applicant: NOVO NORDISK A/S
    Inventors: Liselotte Bjerre Knudsen, Bidda Charlotte Rolin, Richard David Carr, Johan Selmer, Jens Larsen, Bodil Elbrond, Lars Bo Nielsen, Christina Christoffersen
  • GLP-I Agonist And Cardiovascular Complications
    Publication number: 20120295836
    Abstract: Methods and uses for the treatment and prevention of cardiac and cardiovascular diseases comprising administration of a GLP-1 agonist.
    Type: Application
    Filed: April 4, 2012
    Publication date: November 22, 2012
    Applicant: Novo Nordisk A/S
    Inventors: Liselotte Bjerre Knudsen, Bidda Charlotte Rolin, Richard David Carr, Johan Selmer, Jens Larsen, Bodil Elbrond, Lars Bo Nielsen, Christina Christoffersen
  • Use of GLP-1 compound for treatment of critically ill patients
    Patent number: 8088731
    Abstract: Use of medicament for life saving treatment of critically ill patients and method of treatment. The medicament comprises a GLP-1 compound which effectively controls the blood glucose level.
    Type: Grant
    Filed: July 2, 2009
    Date of Patent: January 3, 2012
    Assignee: Novo Nordisk A/S
    Inventors: Lotte Bjerre Knudsen, Johan Selmer, Kristian Tage Hansen
  • GLP-I Agonist And Cardiovascular Complications
    Publication number: 20110230409
    Abstract: Methods and uses for the treatment and prevention of cardiac and cardiovascular diseases comprising administration of a GLP-1 agonist.
    Type: Application
    Filed: June 2, 2011
    Publication date: September 22, 2011
    Applicant: Novo Nordisk A/S
    Inventors: Liselotte Bjerre Knudsen, Bidda Charlotte Rolin, Richard David Carr, Johan Selmer, Jens Larsen, Bodil Elbrond, Lars Bo Nielsen, Christina Christoffersen
  • USE OF GLP-1 COMPOUND FOR TREATMENT OF CRITICALLY ILL PATIENTS
    Publication number: 20100311651
    Abstract: Use of medicament for life saving treatment of critically ill patients and method of treatment. The medicament comprises a GLP-1 compound which effectively controls the blood glucose level.
    Type: Application
    Filed: July 2, 2009
    Publication date: December 9, 2010
    Applicant: Novo Nordisk A/S
    Inventors: Lotte Bjerre Knudsen, Johan Selmer, Kristian Tage Hansen
  • Combined Use Of A GLP-1 Compound And A Modulator Of Diabetic Late Complications
    Publication number: 20100184690
    Abstract: Methods and uses for treatment of diabetic late complications comprising administration of a GLP-1 compound and a modulator of diabetic complications.
    Type: Application
    Filed: March 29, 2010
    Publication date: July 22, 2010
    Applicant: Novo Nordisk A/S
    Inventors: Lotte Bjerre Knudsen, Johan Selmer
  • GLP-I Agonist And Cardiovascular Complications
    Publication number: 20090215688
    Abstract: Methods and uses for the treatment and prevention of cardiac and cardiovascular diseases comprising administration of a GLP-1 agonist.
    Type: Application
    Filed: June 5, 2008
    Publication date: August 27, 2009
    Applicant: Novo Nordisk A/S
    Inventors: Liselotte Bjerre Knudsen, Bidda Charlotte Rolin, Richard David Carr, Johan Selmer, Jens Larsen, Bodil Elbrond, Lars Bo Nielsen, Christina Christoffersen